focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.00
Bid: 13.00
Ask: 16.00
Change: 1.50 (11.54%)
Spread: 3.00 (23.077%)
Open: 13.10
High: 15.00
Low: 13.10
Prev. Close: 13.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

25 Nov 2008 07:00

RNS Number : 7960I
Carclo plc
25 November 2008
 



Carclo plc

Interim Results for the six months ended 30 September 2008

Key Points

Profit before tax up 10.1% at £2.6 million and underlying operating profits, before exceptional charges, up 25.2% at £3.3 million.

Technical Plastics delivered improved profits on higher medical sales

Precision Products increased sales by 40.0% to £14.2 million due to design and development revenues generated from contract wins in specialist lighting.

LED optics business growing rapidly, up 50% on the equivalent period last year

Conductive Inkjet Technology commissioned the MetalJet 6000 at its Cambridge facility

Acquired Jacottet Industrie SA, a French aerospace business

Interim dividend increased by 8.3% to 0.65 pence 

 

Commenting on the results, Christopher Ross, chairman, said -

"Profit progression in the first half was good and was in line with our expectations. Many of the markets we serve are proving resilient and, for the most part, have not been impacted by the current economic downturn. In November we have seen a reduction in demand in automotive and electronics markets, but the continued strength of the specialist medical and optical businesses and design and development revenues will help to mitigate the impact on the group. Whilst global demand remains uncertain, we will maintain our focus on cost control and margin improvement.

Our financing is secure, our strategy is sound and our businesses continue to trade well in a difficult and volatile environment."

 

-ends-

 

For further information please contact:

Carclo plc

Ian Williamson, chief executive

On 25 November 2008: 020 7067 0700

Robert Brooksbank, finance director

Thereafter: 01924 268040

Weber Shandwick Financial 

Terry Garrett

020 7067 0700

James White

 

A presentation for analysts will be held at 9.30 am, on 25 November 2008, at the offices of Weber Shandwick FinancialFox Court, 14 Gray's Inn RoadLondon WC1X 8WS

  

Notes to editors

Carclo plc is a global supplier of technical plastic components. It is a public company whose shares are quoted on the London Stock Exchange.

70% of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, automotive, telecom and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

30% of sales are derived from the supply of manufactured systems to the automotive and aerospace industries.

Carclo's strategy is to grow rapidly in low cost manufacturing regions and to develop new technologies and products to underpin future growth.

 

 Chairman's statement

Overview

Carclo has delivered good profit progression in the six months to 30 September 2008, despite a background of increasingly severe economic turbulence. 

Underlying operating profit before exceptional costs increased by 25.2% to £3.3 million (2007 - £2.6 million) and profit before tax was £2.6 million for the half year, an increase of 10.1% compared to the same period last year. Technical Plastics delivered improved profits on similar turnover to the prior half year period, reflecting the improvement in margins from continued growth in the group's medical business. Precision Products generated profits well ahead of the half year to 30 September 2007 due to a strong inflow of new contracts in its specialist lighting business.

The board has declared an interim dividend of 0.65 pence per ordinary share, an increase of 8.3% on last year (2007 - 0.6 pence). The dividend will be paid on 6 April 2009 to shareholders on the register on 6 March 2009. The shares will be traded excluding the right to the dividend from 4 March 2009.

Financial position

Net debt at 30 September 2008 was £15.9 million representing gearing on assets (excluding the net pension deficit) of 30.3% (2007 - 29.4%). In the six months under review, net debt increased by £2.2 million. This increase in indebtedness was primarily due to the acquisition of Jacottet Industrie SA ("Jacottet") for a net cash cost of £1.6 million as well as a £0.7 million impact from the re-translation of predominantly US dollar denominated net borrowings.

The group sold a surplus property in the period for £0.8 million which resulted in a profit of £0.3 million. The group has three other surplus properties held for sale with a net book value of £1.6 million and which are being actively marketed. However, in the current economic environment, it is difficult to predict when these properties will be sold.

The group re-financed with £20.0 million of new term loan facilities in 2007. These facilities, which are competitively priced, are in place until June 2012. The facility agreements contain a limited number of covenants relative to which the group has a very comfortable level of headroom.

Group strategy

The group's strategy continues to deliver good progress. Medical diagnostics, as expected, saw a sales performance ahead of the prior year and LED optic sales grew by over 50% compared to the first half of last year. Our decision to exit lower margin automotive moulding work in the period was well timed. Expansion of our production in low cost regions continues with the commissioning of an assembly facility in India to service our global customer base.

Investment in new technologies also continues. Conductive Inkjet Technology is set to see a step up in revenues as the manufacture of RFID antennas and printed electronics commences for a range of applications. Platform Diagnostics, in which Carclo now has a 17.5% stake, has made good progress in the research and development of a low cost disposable blood testing device.

Operating review

Technical Plastics

The Technical Plastics division achieved sales of £28.7 million, the same level as in the prior half year period. Increasing medical and LED optic sales offset fully the reduction in automotive moulding turnover. This shift in sales mix to higher quality revenues resulted in operating margins increasing from 5.1% to 6.8%. As a consequence, the division delivered operating profits, before exceptional charges, of £2.0 million compared to £1.5 million in the same period last year. Our UK medical business, in particular, performed well in the first half benefiting from growth in its diagnostic components and new medical device programmes.

 The closure of the group's small automotive mouldings facility in Llanelli, Wales was completed in the period resulting in a total exceptional charge of £0.5 million. In recent months cost pressures in the UK have been increasing. Whilst the Technical Plastics business has been successful in passing on the impact of polymer price increases, the significant increase in energy costs will impact the UK businesses in the second half. However, the increased profits from tooling contracts associated with the new medical programmes and the favourable impact from the re-translation of our US dollar denominated earnings is expected to compensate for these higher energy costs.

In October 2005, Delphi Corporation, a customer of our American moulding business, went into Chapter 11. At that time provision was made to cover 25% of the group's exposure. Given the failure of Delphi to complete its planned financial re-structuring, the board has increased the provision to 80% of the net amount outstanding. This has resulted in an exceptional bad debt charge of £0.2 million.

Precision Products

The Precision Products division delivered an excellent performance in the first half of the financial year. Design and development revenues generated by the contract wins in specialist automotive lighting helped sales to increase by 40.0% to £14.2 million (2007 - £10.2 million) and operating profits to increase from £1.7 million to £2.0 million. Product sales from these new lighting contracts will drive revenue growth from 2010 onwards.

The small precision engineering operation has continued to perform well. On 31 July 2008 the group acquired Jacottet, a small French aerospace business, in order to compliment our existing UK aerospace business. The company's share capital was purchased for £1.6 million, net of cash acquired with the business. Deferred consideration of up to £0.3 million is also expected to be paid in respect of the performance of Jacottet in the twelve months to 30 September 2008. Jacottet has traded well since acquisition.

Conductive Inkjet Technology ("CIT")

Conductive Inkjet Technology has also made good progress with the new MetalJet 6000 line being commissioned at its Cambridge facility. This innovative roll to roll production line for the volume manufacture of printed electronics, including RFID antennas, generated a significant amount of interest at Europe's largest RFID exhibition in October. During the next few weeks, production volume samples will be delivered to a number of leading players in the RFID sector.

We have seen very strong interest in CIT's photolithographic inks which permit very fine lines - invisible to human eye - to be produced. This technology is very effective for the production of touch screen interfaces. We have made significant technical advances which will facilitate high speed roll to roll production of touch screen components.

Technical progress on Photovoltaics has been good and we have two specialised inks which provide a conductivity and efficiency boost to polycrystalline silicon photovoltaics. We are now seeking partners to commercialise this technology.

Risks and uncertainties

In our annual report to shareholders in June 2008 we provided a detailed commentary on the risks faced by the group and the measures put in place to monitor and actively manage these risks. The current volatile and deteriorating economic environment clearly increases the risk profile for all businesses. 

As a manufacturing business, our operational gearing is high and, therefore, the biggest risk would be a substantial reduction in demand as global economic output reduces. Most of the markets served by Carclo, especially medical and aerospace, are uncoupled from general consumer activity and we have yet to see any significant adverse impact in these markets. Were such shifts in demand to take place, Carclo has a proven track record in reacting swiftly to rebalance manufacturing output to meet our customers' requirements.

 

Commodity prices have started to fall sharply in recent weeks. This will take time to filter through to the higher value engineering polymers used by Carclo but we would expect to see reductions in material costs in due course. Energy costs, which have been a major problem in the UK, are also likely to fall in the medium term.

Credit risk remains a major concern and our credit insurer is reducing or eliminating cover on a range of customers, especially in the automotive market. Where appropriate, we are re-negotiating payment terms to reduce our exposure to credit risk.

Since September US dollar exchange rates have strengthened against the euro and the pound. The strengthening US dollar will favourably impact on the translation of our US dollar earnings but will increase the sterling value of our dollar denominated debt.

Finally, as detailed below, the mark to market valuation of the pension fund has become very volatile. This volatility has the potential to impact materially the figures reported under IAS 19 in the income statement and balance sheet. In Carclo's scheme the recurring cash income from the assets currently matches the scheme outgoings, minimising risk to the company.

Pensions

Under IAS 34 "Interim Financial Reporting" the group is required to review the carrying value of the pensions asset or liability at the half year. The recent reduction in equity markets has impacted the value of the pension scheme assets and the increase in corporate bond yields has reduced the scheme liabilities. As a consequence the board has provisionally reflected an IAS 19 deficit of £5.0 million on the balance sheet at 30 September 2008 and this compares to a £0.9 million pension asset as at 31 March 2008. The pension balances will be assessed in full at the year end, together with the regular cost and financing impact for the following financial year. Additional pension contributions of £0.9 million over and above the regular cash contributions were made by the group in October, in accordance with the scheme recovery plan.

Outlook

Profit progression in the first half was good and was in line with our expectations. Many of the markets we serve are proving resilient and, for the most part, have not been impacted by the current economic downturn. In November we have seen a reduction in demand in automotive and electronics markets, but the continued strength of the specialist medical and optical businesses and design and development revenues will help to mitigate the impact on the group. Whilst global demand remains uncertain, we will maintain our focus on cost control and margin improvement.

Our financing is secure, our strategy is sound and our businesses continue to trade well in a difficult and volatile environment.

 

Christopher Ross

25 November 2008

 

Consolidated income statement 

Six months ended 

30 September

 2008

unaudited

Six months ended 

30 September 2007

 unaudited

Year ended

31 March 2008

audited

Notes

£000

£000

£000

Revenue

42,694

38,755

81,274

Underlying operating profit

Operating profit before exceptional costs

3,301

2,636

5,713

- rationalisation costs

4

(542)

(388)

(1,244)

- exceptional bad debts

4

(170)

-

(93)

After exceptional costs

2,589

2,248

4,376

Operating profit before net financing

3

2,589

2,248

4,376

Finance income

5

5,437

5,351

10,668

Finance charge

5

(5,439)

(5,250)

(10,542)

Profit before tax

2,587

2,349

4,502

Income tax expense

6

(323)

(235)

-

Profit after tax but before profit / (loss) on discontinued operations

2,264

2,114

4,502

Profit / (loss) on discontinued operations, net of tax

7

176

-

(250)

Profit after tax

2,440

2,114

4,252

Attributable to:

Equity holders of the parent

2,440

2,155

4,293

Minority interest

-

(41)

(41)

Profit for the period

2,440

2,114

4,252

Earnings per ordinary share

8

Basic - continuing operations

4.0 p

3.9 p

8.1 p

Basic - discontinued operations

0.3 p

- p

(0.4) p

Basic - total

4.3 p

3.9 p

7.7 p

Diluted - continuing operations

4.0 p

3.8 p

8.0 p

Diluted - discontinued operations

0.3 p

- p

(0.4) p

Diluted - total

4.3 p

3.8 p

7.6 p

Dividend per ordinary share

9

Arising in respect of the period

0.65 p

0.6 p

1.9 p

Paid in the period

1.9 p

1.6 p

1.6 p

  Consolidated balance sheet

30 September

2008

unaudited

30 September

2007

unaudited

31 March

2008

audited

Notes

 £000

 £000

 £000

Assets

Intangible assets

31,139

26,122

28,934

Property, plant and equipment

24,613

25,035

25,429

Investments

315

105

265

Deferred tax assets

4,440

4,639

2,273

Retirement benefit assets

10

-

-

857

Total non current assets

60,507

55,901

57,758

Inventories

10,841

8,981

9,661

Trade and other receivables

19,468

16,906

16,632

Cash and cash deposits

5,925

5,995

7,785

Assets classified as held for sale

1,579

842

1,271

Total current assets

37,813

32,724

35,349

Total assets

98,320

88,625

93,107

Liabilities

Interest bearing loans and borrowings

17,011

12,287

14,684

Deferred tax liabilities

4,128

3,628

3,785

Retirement benefit obligations

10

5,000

11,314

-

Other payables

450

750

1,000

Total non current liabilities

26,589

27,979

19,469

Trade and other payables

15,698

13,494

14,078

Current tax liabilities

2,149

1,873

1,919

Dividends payable

-

-

339

Interest bearing loans and liabilities

4,841

7,285

6,847

Total current liabilities

22,688

22,652

23,183

Total liabilities

49,277

50,631

42,652 

Net assets

49,043

37,994

50,455

Equity

Ordinary share capital issued

14

2,859

2,815

2,859 

Share premium

14

3,916

3,002

3,916 

Other reserves

14

3,657

3,670

3,669 

Translation reserve

14

4,077

1,145

3,351 

Retained earnings

14

34,534

27,362

36,660 

Total equity attributable to equity holders of the parent

49,043

37,994

50,455 

  Consolidated statement of cash flows

Six months ended

30 September 

2008

unaudited

Six months ended

30 September 

2007

unaudited

Year ended

31 March 

2008

audited

Notes

£000

£000

£000

Cash generated from operations

11

2,246

1,852

6,942

Interest paid

(537)

(613)

(1,344)

Tax paid

(92)

-

(131)

-

-

-

Net cash from operating activities

1,617

1,239

5,467

Cash flows from investing activities

Proceeds from sale of property, plant and equipment

751

11

47

Interest received

71

121

264

Cash flows on discontinued operations

(46)

-

(100)

Receipt of deferred consideration, net of related costs

-

969

937

Proceeds from sale of investments

-

-

2

Acquisition of business undertaking, net of cash acquired

13

(1,582)

-

(1,406)

Acquisition of minority interest

-

-

(148)

Acquisition of property, plant and equipment

(1,118)

(2,052)

(3,571)

Acquisition of intangible assets - computer software

(7)

(129)

(89)

Acquisition of trade investment

(50)

(53)

(215)

Development expenditure

(455)

(359)

(1,244)

Net cash from investing activities

(2,436)

(1,492)

(5,523)

Cash flows from financing activities

Proceeds from the issue of share capital

-

-

6

Proceeds from sale of own shares

396

-

-

Drawings on term loan facilities

1,768

6,628

18,216

Repayment of borrowings

(217)

(7,565)

(17,288)

Payment of finance lease liabilities

-

(1)

(1)

Dividends paid

(1,074)

(890)

(890)

Net cash from financing activities

873

(1,828)

43

Net increase / (decrease) in cash and cash equivalents

54

(2,081)

(13)

Cash and cash equivalents at beginning of period

1,139

991

991

Effect of exchange rate fluctuations on cash held

108

(4)

161

Cash and cash equivalents at end of period

12

1,301

(1,094)

1,139

  

Consolidated statement of recognised income and expense 

Six months ended

30 September

2008

unaudited

Six months ended

30 September

2007

unaudited

Year ended

31 March

2008

audited

£000

 £000

£000

Foreign exchange translation differences

726

287

2,493

Actuarial (losses) / gains on defined benefit schemes

(6,577)

-

10,339

Taxation on items taken directly to equity

1,841

(406)

(3,300)

Income and expense recognised directly in equity

(4,010)

(119)

9,532

Profit for the period

2,440

2,114

4,252

Total recognised income and expense for the period

(1,570)

1,995

13,784

Attributable to -

Equity holders of the parent

(1,570)

2,036

13,825

Minority interest

-

(41)

(41)

Total recognised income and expense for the period

(1,570)

1,995

13,784

  

Notes on the accounts

1. Basis of preparation

The condensed half year report for the six months ended 30 September 2008 has been prepared on the basis of the accounting policies set out in the audited accounts for the year ended 31 March 2008 and in accordance with the Disclosure and Transparency Rules of the UK Financial Services Authority and the requirements of IAS 34: "Interim Financial Reporting" as adopted by the EU. 

The financial information is unaudited, but has been reviewed by the auditors and their report to the company is set out on page 19.

The half year report does not constitute financial statements as defined in Section 240 of the Companies Act 1985 and does not include all of the information and disclosures required for full annual statements. It should be read in conjunction with the annual report and financial statements for the year ended 31 March 2008 which is available either on request from the company's registered office, Springstone House, PO Box 8827 Dewsbury RoadOssettWF5 9WS or can be downloaded from the corporate website: www.carclo-plc.com.

The comparative figures for the financial year ended 31 March 2008 are not the company's statutory accounts for that financial year. Those accounts have been reported on by the company's auditors and delivered to the Registrar of Companies. The report of the auditors was (i) unqualified, (ii) did not include a reference to any matters which the auditors drew attention by way of emphasis without qualifying their report and (iii) did not contain statements under Section 237 (2) or (3) of the Companies Act.

The half year report was approved by the board of directors on 25 November 2008 and is being sent to shareholders on 5 December 2008. Copies are available from the company's registered office and can also be downloaded from the corporate website. 

The group financial statements have been prepared and approved by the directors in accordance with International Financial Reporting Standards as adopted by the EU ("Adopted IFRSs").

2. Accounting estimates

The preparation of the half year financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. In preparing these half year financial statements, the significant judgements made by management in applying the group's accounting policies and the key source of estimation uncertainty were the same as those applied to the audited consolidated financial statements as at, and for the year ended, 31 March 2008.

3. Segment reporting

At 30 September 2008, the group is organised into two main business segments: Technical Plastics and Precision Products. 

The primary segment reporting format is determined to be business segments as the group's risks and returns are affected predominantly by differences in the products and services provided. Secondary information is reported geographically. The operating business segments are organised and managed separately. 

The Technical Plastics segment supply fine tolerance, injection moulded plastic components, which are used in medical, telecom and electronics products. This business operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

The Precision Products segment supply systems to the automotive and aerospace industries. 

Transfer pricing between business segments is set on an arm's length basis. Segmental revenues and results include transfers between business segments. Those transfers are eliminated on consolidation.

The group's geographical segments are based on the location of the group's assets. Sales to external customers disclosed in geographical segments are based on the geographical location of its customers.

Analysis by business segment

The segment results for the six months ended 30 September 2008 were as follows - 

Technical

Plastics

Precision Products

Unallocated 

Eliminations

Group total

£000

£000

£000

£000

£000

Income Statement

Total revenue

28,686

14,207

94

(293)

42,694

Less inter-segment revenue

(289)

(4)

-

293

-

Total external revenue

28,397

14,203

94

-

42,694

Expenses

(26,441)

(12,242)

(710)

-

(39,393)

Underlying operating profit

1,956

1,961

(616)

-

3,301

Rationalisation costs

(508)

-

(34)

-

(542)

Exceptional bad debts

(170)

-

-

-

(170)

Operating profit before net finance charge

1,278

1,961

(650)

-

2,589

Net finance charge

(2)

Tax

(323)

Profit after tax

2,264

 

The segment results for the six months ended 30 September 2007 were as follows - 

Technical Plastics

Precision Products

Unallocated 

Eliminations

Group total

£000

£000

£000

£000

£000

Income Statement

Total revenue

28,745

10,150

52

(192)

38,755

Less inter-segment revenue

(192)

-

-

192

-

Total external revenue

28,553

10,150

52

-

38,755

Expenses

(27,090)

(8,461)

(568)

-

(36,119)

Underlying operating profit

1,463

1,689

(516)

-

2,636

Rationalisation costs

(366)

-

(22)

-

(388)

Operating profit before net finance income

1,097

1,689

(538)

-

2,248

Net finance income

101

Tax

(235)

Profit after tax

2,114

The segment results for the year ended 31 March 2008 were as follows - 

Technical Plastics  £000

Precision Products  £000 

Unallocated £000

Eliminations  £000

Group

total  £000

Income statement

Total revenue

59,460

22,255

67

(508)

81,274

Less inter-segment revenue

(508)

-

-

508

-

Total external revenue

58,952

22,255

67

-

81,274

Expenses

(55,237)

(18,907)

(1,417)

-

(75,561)

Underlying operating profit

3,715

3,348

(1,350)

-

5,713

Rationalisation costs

(1,078)

(6)

(160)

-

(1,244)

Exceptional bad debts

(45)

-

(48)

-

(93)

Operating profit before net finance income

2,592

3,342

(1,558)

-

4,376

Net finance income

126

Tax

-

Profit after tax

4,502

Analysis by geographical segment by destination

Six months ended

30 September

2008

Six months ended

30 September

2007

Year ended

31 March

2008

£000

£000

 £000

The analysis of revenue by geographic destination was as follows -

United Kingdom

16,769

16,229

33,540

North America

9,655

8,564

17,891

Rest of World

16,270

13,962

29,843

Total external revenue

42,694

38,755

81,274

4. Exceptional costs

Six months ended

30 September

2008

Six months ended

30 September

2007

Year ended

31 March

2008

£000

£000

£000

Rationalisation costs

(542)

(388)

(1,244)

Exceptional bad debts

(170)

-

(93)

Total exceptional costs

(712)

(388)

(1,337)

The rationalisation costs in the period under review related primarily to the closure of a Technical Plastics facility in Wales.

The exceptional bad debt charge in the period under review relates to an additional provision on the net receivable from Delphi Corporation, a US based customer which went into Chapter 11 in October 2005. The provision has been increased from 25% of the net receivable to 80% and reflects the current assessment of the likely settlement.

 

5. Net finance (charge) / income

Six months ended

30 September

2008

Six months ended

30 September

2007

Year ended

31 March

2008

 £000

£000

 £000

Finance revenue

69

158

246

Finance expense

(522)

(637)

(1,267)

Other finance revenue - retirement benefits

5,368

5,193

10,422

Other finance expense - retirement benefits

(4,917)

(4,613)

(9,275)

Total 

(2)

101

126

6. Income tax expense

The half year accounts include a tax charge of 12.5% of profit before tax (2007 - 10.0%) based on the estimated average effective income tax rate for the full year. The group's effective tax rate continues to run at a lower level than the underlying UK tax rate of 28.0% (2007 - 30.0%) as the group continues to benefit from prior period tax losses and tax planning initiatives.

7. Profit / (loss) on discontinued activities, net of tax

The profit / (loss) on discontinued activities, net of tax, comprises -

Six months ended

30 September

2008

Six months ended

30 September

2007

Year ended

31 March

2008

£000

£000

£000

Cash costs incurred in relation to surplus assets arising on the disposal of businesses

(46)

-

(100)

Write down of deferred consideration

-

-

(150)

Profit on disposal of surplus property

322

-

-

Impairment of surplus property

(100)

-

-

Total 

176

-

(250)

In the period under review a surplus UK property was disposed for a cash consideration, net of attributable costs, of £0.8 million and gave rise to a profit of £0.3 million. This property was formerly occupied by the card clothing business which was disposed in June 2005.

 

The impairment of the surplus property relates to a vacant freehold French property, which also was occupied by the card clothing business which was disposed in June 2005. The property is being actively marketed and, in the current economic climate, is receiving offers below its carrying value. Accordingly, an impairment provision has been established to reduce the carrying value to current market expectations of its saleable value. 

8. Earnings per share

The calculation of basic earnings per share is based on the profit attributable to ordinary shareholders of the company divided by the weighted average number of ordinary shares outstanding during the period.

The calculation of diluted earnings per share is based on profit attributable to ordinary shareholders of the company divided by the weighted average number of ordinary shares outstanding during the period (adjusted for dilutive options).

The following details the profit and average number of shares used in calculating the basic and diluted earnings per share -

Six months ended

Six months ended

Year ended

30 September

30 September

31 March

2008

2007

2008

£000

£000

£000

Profit from continuing operations

2,264

2,114

4,502

Minority interest

-

41

41

Profit attributable to ordinary shareholders from continuing operations

2,264

2,155

4,543

Profit / (loss) from discontinued operations

176

-

(250)

Profit attributable to ordinary shareholders

2,440

2,155

4,293

Six months ended

Six months ended

Year ended

30 September

30 September

31 March

2008

2007

2008

Shares

Shares

Shares

Weighted average number of ordinary shares in issue in the period

56,838,958

55,624,060

56,061,842

Effect of share options in issue

423,831

617,316

563,170

Weighted average number of ordinary shares (diluted) in the period

57,262,789

56,241,376

56,625,012

The following table summarises the earnings per share figures based on the above data -

Six months ended

Six months ended

Year ended

30 September

30 September

31 March

2008

2007

2008

pence

pence

pence

Basic - continuing operations

4.0

3.9

8.1

Basic - discontinued operations

0.3

 -

(0.4)

Basic - total

4.3

3.9

7.7

Diluted - continuing operations

4.0

3.8

8.0

Diluted - discontinued operations

0.3

-

(0.4)

Diluted - total

4.3

3.8

7.6

9. Dividends paid and proposed

Ordinary dividends per 5 pence share declared in the period comprised - 

Six months ended

Six months ended

Year ended

30 September

30 September

31 March

2008

2007

2008

£000

£000

£000

Final dividend for 2006/07 (1.2 pence per share)

-

668

668

Interim dividend for 2007/08 (0.6 pence per share)

-

-

339

Final dividend for 2007/08 (1.3 pence per share)

735

-

-

735

668

1,007

The directors are proposing an interim dividend of 0.65 pence per ordinary share for the half year ended 30 September 2008. The dividend payment totalling £0.370 million will be paid on 6 April 2009 to shareholders on the share register at close of business on 6 March 2009.

10. Retirement benefit assets / (obligations)

At 31 March 2008, the group had a retirement benefit asset, as calculated under the provisions of IAS 19: "Employee Benefits", of £0.9 million. Adjusting for contributions and service charges in the period, the net asset would have increased to £1.6 million at 30 September 2008. However, the recent collapse in equity markets has significantly impacted the carrying value of the pension scheme assets, whilst the increase in corporate bond yields has reduced the scheme liabilities. The board have assessed the IAS 19 retirement benefit liability at 30 September 2008 to be £5.0 million and therefore charged £6.6 million through the statement of recognised income and expense with a commensurate adjustment to the related deferred tax balance.

11. Cash generated from operations

Six months ended

Six months ended

Year ended

30 September

30 September

31 March

2008

2007

2008

£000

£000

£000

Profit before financing costs

2,589

2,248

4,376

Adjustments for -

Pension fund contributions in excess of service costs

(269)

(167)

(1,432)

Depreciation charge

1,565

1,469

3,152

Amortisation of intangible assets

85

28

112

Exceptional bad debt provision

170

-

93

Profit on disposal of other plant and equipment

-

(7)

(4)

Write down of assets charged to rationalisation costs

152

-

150

Share based payment charge

97

45

128

Operating cash flow before changes in working capital

4,389

3,616

6,575

Changes in working capital (excluding the effects of acquisition and disposal of subsidiaries)

Increase in inventories

(575)

(753)

(436)

(Increase) / decrease in trade and other receivables

(1,254)

474

827

Decrease in trade and other payables

(314)

(1,485)

(24)

Cash generated from operations

2,246

1,852

6,942

12. Cash and cash equivalents

As at

As at

As at

30 September

30 September

31 March

2008

2007

2008

£000

£000

£000

Cash at bank and in hand

5,925

5,995

7,785

Bank overdrafts

(4,624)

(7,089)

(6,646)

1,301

(1,094)

1,139

13. Acquisition of subsidiary

On 31 July 2008, agreement was reached to acquire all of the share capital of the French aerospace business of Jacottet Industrie SA., for a cash consideration of € 2.525 million with a further payment of up to € 0.4 million payable dependant upon the performance of the business in the year to 30 September 2008.

The acquisition had the following effect on the group's assets and liabilities -

Acquiree's book value

Fair value adjustments

 Acquisition amounts

£000

£000

£000

Property, plant and equipment

132

-

132

Intangible assets

165

(87)

78

Inventories

478

(104)

374

Trade and other receivables

1,502

(31)

1,471

Trade and other payables

(1,164)

(94)

(1,258)

Net cash

487

-

487

Net identifiable assets and liabilities

1,600

(316)

1,284

Settled by -

Consideration paid

2,008

Deferred consideration

314

Acquisition costs

241

Goodwill

(1,279)

1,284

The net cash flows in the period arising on the acquisition were -

Consideration paid

2,008

Acquisition costs

61

Net cash acquired with the business

(487)

Net cash outflow

1,582

The fair value adjustments to the assets acquired related to the alignment of accounting policies with Carclo plc and the fair value associated with Jacottet's European customer base.

Goodwill has arisen on the acquisition of Jacottet at a premium to net assets and paid to secure a leading position in the supply of aerospace components, primarily to European markets.

14. Statement of changes in shareholder's equity

Attributable to equity holders of the company

Share

Share

premium

Translation

Other

Retained

Minority

Total

capital

account

reserve

reserves

earnings

Total

interest

equity

£000

£000

£000

£000

£000

£000

£000

£000

Current half year period

Balance at 1 April 2008

2,859

3,916

3,351

3,669

36,660

50,455

-

50,455

Total recognised income and expense

-

-

726

-

(2,296)

(1,570)

-

(1,570)

Transfer in respect of depreciation

-

-

-

(12)

12

-

-

-

Share based payments

-

-

-

-

97

97

-

97

Dividends to shareholders

-

-

-

-

(735)

(735)

-

(735)

Adjustment to deferred consideration

-

-

-

-

400

400

-

400

Proceeds from sale of own shares

-

-

-

-

396

396

-

396

Balance at 30 September 2008

2,859

3,916

4,077

3,657

34,534

49,043

-

49,043

Prior half year period

Balance at 1 April 2007

2,815

3,002

858

3,670

26,900

37,245

1,196

38,441

Total recognised income and expense

-

-

287

-

1,749

2,036

(41)

1,995

Share based payments

-

-

-

-

45

45

-

45

Dividends to shareholders

-

-

-

-

(667)

(667)

-

(667)

Acquisition of minority interest

-

-

-

-

(665)

(665)

(1,155)

(1,820)

Balance at 30 September 2007

2,815

3,002

1,145

3,670

27,362

37,994

-

37,994

Prior year period

Balance at 1 April 2007

2,815

3,002

858

3,670

26,900

37,245

1,196

38,441

Total recognised income and expense

-

-

2,493

-

11,332

13,825

(41)

13,784

Transfer in respect of depreciation

-

-

-

(1)

1

-

-

-

Share based payments

-

-

-

-

128

128

-

128

Dividends to shareholders

-

-

-

-

(1,007)

(1,007)

-

(1,007)

Issue of share capital

44

914

-

-

-

958

-

958

Acquisition of minority interest

-

-

-

-

(694)

(694)

(1,155)

(1,849)

Balance at 31 March 2008

2,859

3,916

3,351

3,669

36,660

50,455

-

50,455

The company maintains an employee share ownership plan for the benefit of employees and which can be used in conjunction with any of the group's share option schemes. As at 30 September 2008 the plan held 183,077 shares (31 March 2008 - 683,077 shares). On 8 August 2008, 500,000 shares were sold for 80 pence per share giving rise to a net cash inflow of £396,000 after commission charges. 

On 30 September 2007, Carclo acquired the minority holding in Conductive Inkjet Technology. The cost of acquiring the minority holding included a deferred consideration element totalling £750,000, contingent upon the achievement of specific sales and profits in the period to 31 March 2010. Based upon the performance of the business in the period under review and current forecast for the business to 31 March 2010, the board have concluded that deferred consideration of up to £350,000 is likely to be paid. Therefore the balance of £400,000 on the deferred consideration provision has been released and credited to retained earnings, in line with how the acquisition of the minority interest was originally accounted.

15. Ordinary share capital

Ordinary shares of 5 pence each:

Number of shares

£000

Authorised at 30 September 2007, 31 March 2008 and 30 September 2008

80,000,000

4,000

Issued and fully paid at 30 September 2007

56,307,137

2,815

Share issued in consideration of the acquisition of shares in Conductive Inkjet Technology Limited

869,565

43

Shares issued on exercise of share options for cash

12,000

1

Issued and fully paid at 31 March 2008 and 30 September 2008

57,188,702

2,859

16. Related parties

Identity of related parties

The group has a related party relationship with its subsidiaries, its directors and executive officers and the group pension schemes.

Transactions with key management personnel

Details of directors' remuneration are disclosed in the group's annual report.

Group pension schemes

Carclo manages a pensions department which administers the group pension scheme. The associated investment costs are recharged to the schemes in full. The costs in the six months ended 30 September 2008 amounted to £0.206 million (2007 - £0.139 million). From 1 April 2007, it has been agreed with the Trustees of the Pension Schemes that, under the terms of the recovery plan, Carclo would bear the scheme's administration costs whilst ever the scheme was in deficit, as calculated at the triennial valuation. As the scheme was in deficit under the latest actuarial valuation, Carclo incurred an administration cost of £0.269 million which has been charged against the IAS 19 pension scheme deficit (2007 - £0.167 million). 

17. Post Balance sheet events

In October 2008, the group injected £0.9 million in cash into the group pension scheme in accordance with the agreed funding plan.

18. Responsibility statement

We confirm that to the best of our knowledge -

 

a) The condensed set of half year financial statements has been prepared in accordance with IAS 34: “Interim Financial Reporting” as adopted by the EU; and
 
b) The half year report includes a fair review of the information required by the Disclosure and Transparency Rules (DTR) 4.2.7R (indication of important events during the first six months and their impact on the financial statements and description of principal risks and uncertainties for the remaining six months of the year); and
 
c) The half year report includes a fair review of the information required by DTR 4.2.8R (disclosure of related party transactions and changes therein).

By order of the board

 

Ian Williamson - chief executive

Robert Brooksbank - finance director

  

INDEPENDENT REVIEW REPORT TO CARCLO PLC

Introduction

We have been engaged by the company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 September 2008 which comprises the unaudited consolidated income statement, the unaudited consolidated statement of recognised income and expense, the unaudited consolidated balance sheet, the unaudited statement of cash flows and the related explanatory notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

This report is made solely to the company in accordance with the terms of our engagement to assist the company in meeting the requirements of the Disclosure and Transparency Rules ("the DTR") of the UK's Financial Services Authority ("the UK FSA"). Our review has been undertaken so that we might state to the company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or for the conclusions we have reached.

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FSA.

As disclosed in note 1, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the EU. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the EU.

Our responsibility

Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review. 

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 September 2008 is not prepared, in all material respects, in accordance with IAS 34 as adopted by the EU and the DTR of the UK FSA.

KPMG Audit Plc

Chartered Accountants

1, The Embankment,

Neville Street

Leeds

LS1 4DW

25 November 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EZLFLVFBBFBD
Date   Source Headline
30th Apr 20247:00 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.